Hitachi

The company is now commencing a trial of the test platform in 250 patients to generate more data while it considers how to best commercialize it.

The companies are aiming to develop and establish clinical operation for the assays in Japan, where Hitachi said there is growing demand for such tests.

PSS, which develops tools for the IVD space, will supply to Hitachi its nucleic acid isolation system, fully automated diagnostic instruments, and reagents.

The firms will develop a test to measure total IgE in human tears for diagnosing allergic conjunctivitis.